Modular femoral revision system yielded excellent component survivorship
Use of a specific modular femoral revision system yielded excellent component survivorship for patients undergoing revision total hip arthroplasty, according to results.
Researchers evaluated component survivorship and time to re-revision THA among 51 patients undergoing revision THA with the Arcos Modular Femoral Revision System (Zimmer Biomet).
Results showed 13.7% of patients underwent secondary revision THA. Researchers found a mean time to re-revision THA of approximately 4.88 months. At 60 months, patients had a Kaplan-Meier survivorship using re-revision for any reason of 86.3%.
“Component survivorship was 93.2% at 60 months when excluding infection and postoperative femur fractures due to falls, and all-included component survivorship was 86.3% at 60 months,” the authors wrote. “This study showed promising early results in survivorship and subsidence for the Arcos Modular Femoral Revision System.” – by Casey Tingle
Disclosures: The authors report no relevant financial disclosures.